[
    [
        {
            "time": "",
            "original_text": "医药生物行业周报：中药板块涨势亮眼 医保目录调整方案正式落地",
            "features": {
                "keywords": [
                    "中药板块",
                    "涨势亮眼",
                    "医保目录",
                    "调整方案"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周报：中药板块涨势亮眼 医保目录调整方案正式落地",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "速递 | 23亿美元助力开发神经退行性疾病创新疗法，葛兰素史克达成合作",
            "features": {
                "keywords": [
                    "神经退行性疾病",
                    "创新疗法",
                    "葛兰素史克",
                    "合作"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "速递 | 23亿美元助力开发神经退行性疾病创新疗法，葛兰素史克达成合作",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "速递 | 有机砷抗癌疗法在日本提交新药申请，治疗淋巴瘤",
            "features": {
                "keywords": [
                    "有机砷",
                    "抗癌疗法",
                    "新药申请",
                    "淋巴瘤"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "癌症治疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "速递 | 有机砷抗癌疗法在日本提交新药申请，治疗淋巴瘤",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]